Severe meticillin-resistant Staphylococcus aureus infections: Emergence of resistance to fucidic acid or fosfomycin in patients given continuous infusion of vancomycin;Infections severes a Staphylococcus aureus meticillino-resistants: Emergence de resistance a l'acid fusidique ou a la fosfomycine lors du traitement par vancomycine en perfusion continue

Presse Medicale

Volumn 26, Issue 11, 1997, Pages 502-506

  Georges, B ^a   Brown, L ^a   Mazerolles, M ^a   Decun, J F ^a   Cougot, P ^a   Archambaud, M ^a   Suc, C ^a   Andrieu, P ^a   Virenque, C ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOSFOMYCIN; FUSIDIC ACID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; INFECTION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; DRUG COMBINATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; TIME;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; FOSFOMYCIN; FUSIDIC ACID; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; VANCOMYCIN;

EID: 0031553877     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. e Congrès National d'Anesthésie et de Réanimation, Masson, Paris 1993 ; 601-20.
2. Besnier JM, Choutet P. Traitement des infections systémiques à Staphylococcus aureus chez l'adulte. La Lettre de l'Infectiologue 1995 ; 9:444-8.
3. Besnier JM, Kanoun F, Martin C, Cotty P, Fenneteau A, Choutet P. Failure of a combination of vancomycin and fusidic acid in a patient with staphylococcal infection. J Antimicrob Chemother 1991 ; 27:560-2.
4. Lucet JC, Wolff M, Bedos JP, Decre D, Regnier B, Vachon F. Development of rifampin resistance during vancomycin plus rifampin treatment of severe Methicillin-resistant Staphylococcus aureus infection. In: 30th Interscience Conference of Antimicrobial Agents and Chemotherapy, Atlanta, 1990, 474, 21-24.
5. Garraffo R. A new approach to otpimal antibiotic dosage regimen by coupling pharmacokinetics in killing cure parameters. Meth Find Exp Clin Pharmacol 1990 ; 12:325-32.
6. Krogstad DJ, Moellering RC, Greenblatt DJ. Single-dose kinetics of intravenous vancomycin. J Clin Pharmocol 1980 ; 20:197-201.
7. Healy DP, Polk RE, Carson ML, Rock DT, Comstock TJ. Comparison of steady state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Antimicrob Agents Chemother 1987 ; 81:393-7.
8. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in Methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991 ; 115:674-80.
9. Wysocki M, Thomas F, Wolff MA, Pean Y, Ravaud Y, Herman B. Comparison of continuous with discontinous intravenous infusion of vancomycin in severe MRSA infections. J Antimicrob Chemother 1995 ; 35:352-4.
10. Conil JM, Favarel H, Laguerre J et al. Vancomycine en administration continue chez le grand brûlé. Press Med 1994 ; 23:1554-8.
11. Duffull SB, Begg EJ, Chambers ST, Barclay ML. Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model. J Antimicrob Chemother 1994 ; 38:2480-2.
12. Reverdy ME, Roure CH. Les antistaphylococciques en 1995 : état actuel de la sensibilité de Staphylococcus aureus. La lettre de l'Infectiologue 1995 ; 9:362-71.
13. Thomas F, Michel P, Ravaud Y. Traitement d'infections à staphylocoques chez l'adulte par perfusion veineuse continue de vancomycine en monothérapie. Sem Hop Paris 1988 ; 64:215-18.
14. Portier H. A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infections. J Antimicrob Chemother 1990 ; 25 (suppl. B):39-44.